Inventor · disambiguated record

Roland Kreutzer

Also filed as: KREUTZER ROLAND

27 granted patents·12 pending applications·516 citations·filing 2002–2018

97Inventor score

Technology areasA61P C12N A61K

Files withALNYLAM PHARMACEUTICALS INC13 KREUTZER ROLAND12 RIBOPHARMA AG4 ALNYLAM EUROPE AG3 JOHN MATTHIAS2

Top patents by PatentIndex Score

39 records

0196US8546143B2Compositions and methods for inhibiting expression of a target geneKREUTZER ROLAND·Filed 2010·Granted Oct 1, 2013·47 cites·18 claims
0296US8101584B2Method and medicament for inhibiting the expression of a given geneKREUTZER ROLAND·Filed 2003·Granted Jan 24, 2012·54 cites·10 claims
0396US7829693B2Compositions and methods for inhibiting expression of a target geneALNYLAM PHARMACEUTICALS INC·Filed 2003·Granted Nov 9, 2010·134 cites·6 claims
0495US8101742B2Method and medicament for inhibiting the expression of a given geneKREUTZER ROLAND·Filed 2007·Granted Jan 24, 2012·18 cites·24 claims
0594US7348314B2Compositions and methods for inhibiting viral replicationALNYLAM EUROPE AG·Filed 2003·Granted Mar 25, 2008·45 cites·3 claims
0692US8114851B2Method and medicament for inhibiting the expression of a given geneKREUTZER ROLAND·Filed 2007·Granted Feb 14, 2012·10 cites·11 claims
0791US7196184B2Double-stranded RNA (DSRNA) and method of use for inhibiting expression of the AML-1/MTG8 fusion geneALNYLAM EUROPE AG·Filed 2003·Granted Mar 27, 2007·26 cites·2 claims
0890US8183362B2Method and medicament for inhibiting the expression of a given geneKREUTZER ROLAND·Filed 2007·Granted May 22, 2012·7 cites·16 claims
0990US8114981B2Method and medicament for inhibiting the expression of a given geneKREUTZER ROLAND·Filed 2007·Granted Feb 14, 2012·7 cites·22 claims
1090US7994309B2Compositions and methods for inhibiting expression of a mutant geneALNYLAM PHARMACEUTICALS INC·Filed 2010·Granted Aug 9, 2011·6 cites·32 claims
1189US7846907B2Double-stranded RNA (dsRNA) and method of use for inhibiting expression of a fusion geneALNYLAM PHARMACEUTICALS INC·Filed 2007·Granted Dec 7, 2010·5 cites·8 claims
1288US7473525B2Compositions and methods for inhibiting expression of anti-apoptotic genesALNYLAM EUROPE AG·Filed 2003·Granted Jan 6, 2009·53 cites·4 claims
1387US8202980B2Method and medicament for inhibiting the expression of a given geneKREUTZER ROLAND·Filed 2003·Granted Jun 19, 2012·14 cites·17 claims
1487US8168776B2Method for making a 21 nucleotide double stranded RNA chemically linked at one endKREUTZER ROLAND·Filed 2003·Granted May 1, 2012·14 cites·8 claims
1586US7745418B2Compositions and methods for inhibiting viral replicationALNYLAM PHARMACEUTICALS INC·Filed 2007·Granted Jun 29, 2010·4 cites·28 claims
1685US8877726B2Method and medicament for inhibiting the expression of a given geneALNYLAM PHARMACEUTICALS INC·Filed 2012·Granted Nov 4, 2014·3 cites·18 claims
1785US8273868B2Compositions and methods for inhibiting viral replicationJOHN MATTHIAS·Filed 2009·Granted Sep 25, 2012·7 cites·24 claims
1885US8273870B2Compositions and methods for inhibiting expression of a mutant geneKREUTZER ROLAND·Filed 2011·Granted Sep 25, 2012·6 cites·33 claims
1985US8119608B2Method and medicament for inhibiting the expression of a given geneKREUTZER ROLAND·Filed 2003·Granted Feb 21, 2012·11 cites·14 claims
2083US9133454B2Method and medicament for inhibiting the expression of a given geneALNYLAM PHARMACEUTICALS INC·Filed 2014·Granted Sep 15, 2015·2 cites·16 claims
2183US7763590B2Compositions and methods for inhibiting expression of a mutant geneALNYLAM PHARMACEUTICALS INC·Filed 2003·Granted Jul 27, 2010·15 cites·7 claims
2282US7700572B2SMAD7 inhibitors for the treatment of CNS diseasesGIULIANI INTERNATIONAL LTD·Filed 2002·Granted Apr 20, 2010·24 cites·4 claims
2379US9587240B2Compositions and methods for inhibiting expression of a target geneALNYLAM PHARMACEUTICALS INC·Filed 2015·Granted Mar 7, 2017·2 cites·20 claims
2476US9074213B2Compositions and methods for inhibiting expression of a target geneALNYLAM PHARMACEUTICALS INC·Filed 2013·Granted Jul 7, 2015·2 cites·15 claims
2570US9902955B2Method and medicament for inhibiting the expression of a given geneALNYLAM PHARMACEUTICALS INC·Filed 2014·Granted Feb 27, 2018·0 cites·25 claims
2670US2018179526A1Method and Medicament For Inhibiting The Expression of A Given GeneALNYLAM PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
2768US8729037B2Method and medicament for inhibiting the expression of a given geneKREUTZER ROLAND·Filed 2007·Granted May 20, 2014·0 cites·12 claims
2867US9902954B2Method and medicament for inhibiting the expression of a given geneALNYLAM PHARMACEUTICALS INC·Filed 2012·Granted Feb 27, 2018·0 cites·24 claims
2966US2013177631A1Method and medicament for inhibiting the expression of a given geneALNYLAM PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
3064US2011207795A1Smad7 inhibitor compositions and uses thereofSTEINBRECHER ANDREAS·Filed 2009·Application pending·0 cites
3157US2013064879A1Compositions and Methods for Inhibiting Viral ReplicationJOHN MATTHIAS·Filed 2012·Application pending·0 cites
3257US2004038921A1Composition and method for inhibiting expression of a target geneRIBOPHARMA AG·Filed 2003·Application pending·0 cites
3356US2005119202A1Medicament to treat a fibrotic diseaseFiled 2002·Application pending·0 cites
3455US2004248835A1Use of a double-stranded ribonucleic acid for treating an infection with a positivestrand rna-virusFiled 2002·Application pending·0 cites
3554US2012322858A1Compositions and Methods for Inhibiting Expression of a Mutant GeneKREUTZER ROLAND·Filed 2012·Application pending·0 cites
3650US2011065777A1DOUBLE-STRANDED RNA (dsRNA) AND METHOD OF USE FOR INHIBITING EXPRESSION OF A FUSION GENEHEIDENREICH OLAF·Filed 2010·Application pending·0 cites
3750US2004126791A1Compositions and methods for treating trail-resistant cancer cellsRIBOPHARMA AG·Filed 2003·Application pending·0 cites
3846US2008070856A1Medicament to treat a fibrotic diseaseRIBOPHARMA AG·Filed 2007·Application pending·0 cites
3938US2004121348A1Compositions and methods for treating pancreatic cancerRIBOPHARMA AG·Filed 2003·Application pending·0 cites

Join the waitlist — get patent alerts

Get an alert when Roland Kreutzer files or is granted a new patent.

We store only your email — no account needed. See our privacy policy.

Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →